This trial will compare whether a weight-loss intervention can help prevent prostate cancer progression, compared to standard care.
- Prostate Cancer
1 Primary · 3 Secondary · Reporting Duration: 6 months, 12 months, and 24 months
2 Treatment Groups
Standard of Care
1 of 2
1 of 2
130 Total Participants · 2 Treatment Groups
Primary Treatment: EMPOWER · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · Male Participants · 14 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are admitted into this research experiment?
"Affirmative. According to clinicaltrials.gov, this medical investigation is open for recruitment. The experiment was announced on February 20th 2020 and the latest update occurred on March 18th 2022; 130 participants must be sourced from one location in total." - Anonymous Online Contributor
Is this research project open to new enrollees?
"This trial, which was initially published on February 20th 2020 and recently revised March 18th 2022, is currently seeking participants. Data hosted by clinicaltrials.gov confirms this fact." - Anonymous Online Contributor